Evidence map›Paper›PMID 23257943›Full record

ArticleBMJ case reports2012

Solitaire FR device for treatment of dural sinus thrombosis.

Bryan Anthony Pukenas, Monisha Kumar, Michael Stiefel, Michelle Smith, Robert Hurst

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Endovascular treatments for cerebral venous sinus thrombosis.Journal of thrombosis and thrombolysis · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bryan Anthony PukenasDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. bryan.pukenas@uphs.upenn.edu
Monisha Kumar
Michael Stiefel
Michelle Smith
Robert Hurst

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dural venous sinus thrombosis is a rare and potentially devastating disease. Several predisposing factors exist, including oral contraceptive therapy and colitis. First-line therapy consists of systemic anticoagulation. If first-line therapies fail, more aggressive endovascular therapies may be performed. We report our initial experience with the Solitaire FR device for treatment of refractory symptomatic dural venous sinus thrombosis.

Indexed as

Cranial SinusesEquipment DesignFemaleHumansThrombosisVascular Surgical ProceduresYoung Adult

Identifiers

PMID23257943
PMCPMC4545054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.